Lazar, Nathan H.
Celik, Safiye
Chen, Lu
Fay, Marta M.
Irish, Jonathan C.
Jensen, James
Tillinghast, Conor A.
Urbanik, John
Bone, William P.
Gibson, Christopher C.
Haque, Imran S. http://orcid.org/0000-0001-7782-2852
Article History
Received: 30 June 2023
Accepted: 18 April 2024
First Online: 29 May 2024
Competing interests
: All authors are current or former employees of Recursion Pharmaceuticals, Inc., and have received real or optional ownership interest in the company.